290 related articles for article (PubMed ID: 25666264)
1. Prognostic impact of transcription factor Fra-1 in ER-positive breast cancer: contribution to a metastatic phenotype through modulation of tumor cell adhesive properties.
Oliveira-Ferrer L; Kürschner M; Labitzky V; Wicklein D; Müller V; Lüers G; Schumacher U; Milde-Langosch K; Schröder C
J Cancer Res Clin Oncol; 2015 Oct; 141(10):1715-26. PubMed ID: 25666264
[TBL] [Abstract][Full Text] [Related]
2. The transcription factor Fra-2 promotes mammary tumour progression by changing the adhesive properties of breast cancer cells.
Schröder C; Schumacher U; Müller V; Wirtz RM; Streichert T; Richter U; Wicklein D; Milde-Langosch K
Eur J Cancer; 2010 Jun; 46(9):1650-60. PubMed ID: 20226654
[TBL] [Abstract][Full Text] [Related]
3. Fra-2 overexpression upregulates pro-metastatic cell-adhesion molecules, promotes pulmonary metastasis, and reduces survival in a spontaneous xenograft model of human breast cancer.
Arnold S; Kortland J; Maltseva DV; Nersisyan SA; Samatov TR; Lezius S; Tonevitsky AG; Milde-Langosch K; Wicklein D; Schumacher U; Stürken C
J Cancer Res Clin Oncol; 2022 Jun; 148(6):1525-1542. PubMed ID: 34693476
[TBL] [Abstract][Full Text] [Related]
4. FRA-1 expression level modulates regulation of activator protein-1 activity by estradiol in breast cancer cells.
Philips A; Teyssier C; Galtier F; Rivier-Covas C; Rey JM; Rochefort H; Chalbos D
Mol Endocrinol; 1998 Jul; 12(7):973-85. PubMed ID: 9658402
[TBL] [Abstract][Full Text] [Related]
5. FRA-1 expression level regulates proliferation and invasiveness of breast cancer cells.
Belguise K; Kersual N; Galtier F; Chalbos D
Oncogene; 2005 Feb; 24(8):1434-44. PubMed ID: 15608675
[TBL] [Abstract][Full Text] [Related]
6. Blocking the adhesion cascade at the premetastatic niche for prevention of breast cancer metastasis.
Kang SA; Hasan N; Mann AP; Zheng W; Zhao L; Morris L; Zhu W; Zhao YD; Suh KS; Dooley WC; Volk D; Gorenstein DG; Cristofanilli M; Rui H; Tanaka T
Mol Ther; 2015 Jun; 23(6):1044-1054. PubMed ID: 25815697
[TBL] [Abstract][Full Text] [Related]
7. High-density lipoprotein of patients with breast cancer complicated with type 2 diabetes mellitus promotes cancer cells adhesion to vascular endothelium via ICAM-1 and VCAM-1 upregulation.
Huang X; He D; Ming J; He Y; Zhou C; Ren H; He X; Wang C; Jin J; Ji L; Willard B; Pan B; Zheng L
Breast Cancer Res Treat; 2016 Feb; 155(3):441-55. PubMed ID: 26872904
[TBL] [Abstract][Full Text] [Related]
8. Biologic role of activated leukocyte cell adhesion molecule overexpression in breast cancer cell lines and clinical tumor tissue.
Hein S; Müller V; Köhler N; Wikman H; Krenkel S; Streichert T; Schweizer M; Riethdorf S; Assmann V; Ihnen M; Beck K; Issa R; Jänicke F; Pantel K; Milde-Langosch K
Breast Cancer Res Treat; 2011 Sep; 129(2):347-60. PubMed ID: 20972617
[TBL] [Abstract][Full Text] [Related]
9. Role of Fra-2 in breast cancer: influence on tumor cell invasion and motility.
Milde-Langosch K; Janke S; Wagner I; Schröder C; Streichert T; Bamberger AM; Jänicke F; Löning T
Breast Cancer Res Treat; 2008 Feb; 107(3):337-47. PubMed ID: 17393299
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-34 suppresses breast cancer invasion and metastasis by directly targeting Fra-1.
Yang S; Li Y; Gao J; Zhang T; Li S; Luo A; Chen H; Ding F; Wang X; Liu Z
Oncogene; 2013 Sep; 32(36):4294-303. PubMed ID: 23001043
[TBL] [Abstract][Full Text] [Related]
11. FOXP3 suppresses breast cancer metastasis through downregulation of CD44.
Zhang C; Xu Y; Hao Q; Wang S; Li H; Li J; Gao Y; Li M; Li W; Xue X; Wu S; Zhang Y; Zhang W
Int J Cancer; 2015 Sep; 137(6):1279-90. PubMed ID: 25683728
[TBL] [Abstract][Full Text] [Related]
12. cJun overexpression in MCF-7 breast cancer cells produces a tumorigenic, invasive and hormone resistant phenotype.
Smith LM; Wise SC; Hendricks DT; Sabichi AL; Bos T; Reddy P; Brown PH; Birrer MJ
Oncogene; 1999 Oct; 18(44):6063-70. PubMed ID: 10557095
[TBL] [Abstract][Full Text] [Related]
13. CD44 variant isoforms expressed by breast cancer cells are functional E-selectin ligands under flow conditions.
Shirure VS; Liu T; Delgadillo LF; Cuckler CM; Tees DF; Benencia F; Goetz DJ; Burdick MM
Am J Physiol Cell Physiol; 2015 Jan; 308(1):C68-78. PubMed ID: 25339657
[TBL] [Abstract][Full Text] [Related]
14. Integrin-uPAR signaling leads to FRA-1 phosphorylation and enhanced breast cancer invasion.
Annis MG; Ouellet V; Rennhack JP; L'Esperance S; Rancourt C; Mes-Masson AM; Andrechek ER; Siegel PM
Breast Cancer Res; 2018 Jan; 20(1):9. PubMed ID: 29382358
[TBL] [Abstract][Full Text] [Related]
15. The role of the AP-1 transcription factors c-Fos, FosB, Fra-1 and Fra-2 in the invasion process of mammary carcinomas.
Milde-Langosch K; Röder H; Andritzky B; Aslan B; Hemminger G; Brinkmann A; Bamberger CM; Löning T; Bamberger AM
Breast Cancer Res Treat; 2004 Jul; 86(2):139-52. PubMed ID: 15319566
[TBL] [Abstract][Full Text] [Related]
16. Old players with a newly defined function: Fra-1 and c-Fos support growth of human malignant breast tumors by activating membrane biogenesis at the cytoplasm.
Motrich RD; Castro GM; Caputto BL
PLoS One; 2013; 8(1):e53211. PubMed ID: 23301044
[TBL] [Abstract][Full Text] [Related]
17. The molecular role of Fra-1 and its prognostic significance in human esophageal squamous cell carcinoma.
Usui A; Hoshino I; Akutsu Y; Sakata H; Nishimori T; Murakami K; Kano M; Shuto K; Matsubara H
Cancer; 2012 Jul; 118(13):3387-96. PubMed ID: 22028113
[TBL] [Abstract][Full Text] [Related]
18. The effect of soluble E-selectin on tumor progression and metastasis.
Kang SA; Blache CA; Bajana S; Hasan N; Kamal M; Morita Y; Gupta V; Tsolmon B; Suh KS; Gorenstein DG; Razaq W; Rui H; Tanaka T
BMC Cancer; 2016 May; 16():331. PubMed ID: 27220365
[TBL] [Abstract][Full Text] [Related]
19. PKCθ-induced phosphorylations control the ability of Fra-1 to stimulate gene expression and cancer cell migration.
Belguise K; Cherradi S; Sarr A; Boissière F; Boulle N; Simony-Lafontaine J; Choesmel-Cadamuro V; Wang X; Chalbos D
Cancer Lett; 2017 Jan; 385():97-107. PubMed ID: 27816489
[TBL] [Abstract][Full Text] [Related]
20. Two E-selectin ligands, BST-2 and LGALS3BP, predict metastasis and poor survival of ER-negative breast cancer.
Woodman N; Pinder SE; Tajadura V; Le Bourhis X; Gillett C; Delannoy P; Burchell JM; Julien S
Int J Oncol; 2016 Jul; 49(1):265-75. PubMed ID: 27176937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]